| Prof Wendy Cooper |
| Royal Prince Alfred Hospital |
| Lung Cancer |
| Diagnostic |
Key outcomes:
- Prof Cooper’s team now routinely screen all lung adenocarcinoma cases.
- Awarded a landmark $14.7m Frontier Health and Medical Research grant for groundbreaking lung cancer liquid biopsy trial
- Cancer mutation testing is being used to characterise tumour pathology and identify suitable and personalised drugs for patients
- Approval of new therapies and concurrent diagnostics by PBAC and MSAC
- New clinical trials in association with pharmaceutical companies are being undertaken.
- in 2017, Prof Cooper was awarded the John Raftos Medal for her innovative research and its application.
“I am extremely grateful for the wonderful opportunities the funding from NFMRI have given me and my research team. I am proud that we are making an impact on lung cancer diagnostics in Australia.”